Original Investigation
Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus

https://doi.org/10.1016/j.jacc.2017.07.792Get rights and content
Under an Elsevier user license
open archive

Abstract

Background

Type 2 diabetes mellitus (T2DM) may alter cardiac structure and function, but obesity, hypertension (HTN), or aging can induce similar abnormalities.

Objectives

This study sought to link cardiac phenotypes in T2DM patients with clinical profiles and outcomes using cluster analysis.

Methods

Baseline echocardiography and a composite endpoint (cardiovascular mortality and hospitalization) were evaluated in 842 T2DM patients from 2 prospective cohorts. A cluster analysis was performed on echocardiographic variables, and the association between clusters and clinical profiles and outcomes was assessed.

Results

Three clusters were identified. Cluster 1 patients had the lowest left ventricular (LV) mass index and ratio between early mitral inflow velocity and mitral annular early diastolic velocity (E/e′) ratio, had the highest left ventricular ejection fraction (LVEF), and were predominantly male with the lowest rate of obesity or HTN. Cluster 2 patients had the highest strain and highest E/e′ ratio, were the oldest, were predominantly female, and had the lowest rate of isolated T2DM (without HTN or obesity). Cluster 3 patients had the highest LV mass index and volumes and the lowest LVEF and strain, were predominantly male, and shared similar age and rate of obesity and HTN as cluster 1 patients. After follow-up of 67 months (interquartile range: 40 to 87), the composite endpoint occurred in 56 of 521 patients (10.8%). Clusters 2 (hazard ratio: 2.37; 95% confidence interval: 1.15 to 4.88) and 3 (hazard ratio: 2.19; 95% confidence interval: 1.00 to 4.82) had a similar outcome, which was worse than cluster 1.

Conclusions

Cluster analysis of echocardiographic variables identified 3 different echocardiographic phenotypes of T2DM patients that were associated with distinct clinical profiles and highlighted the prognostic value of LV remodeling and subclinical dysfunction.

Key Words

diabetic cardiomyopathy
diabetic heart disease
myocardial strain
prognosis
subclinical myocardial disease

Abbreviations and Acronyms

A
peak late diastolic velocity
BMI
body mass index
CI
confidence interval
E
peak early diastolic velocity
e′
mitral annular early diastolic velocity
e′ lateral
early diastolic velocity at the lateral site of the mitral annulus
e′ septal
early diastolic velocity at the septal site of the mitral annulus
HbA1c
glycosylated hemoglobin
HF
heart failure
HR
hazard ratio
HTN
hypertension
LA
left atrium
LV
left ventricle
LVEDV
left ventricular end-diastolic volume
LVEF
left ventricular ejection fraction
LVESV
left ventricular end-systolic volume
LVMi
left ventricular mass indexed to body surface area
T2DM
type 2 diabetes mellitus

Cited by (0)

This work was supported by a grant from the Société Francophone du Diabète (formerly the Association of French Language for the Study of Diabetes Mellitus and Metabolic Diseases, grant number D20515) and a grant from the Programme Hospitalier de Recherche Clinique (PHRC 2009-A00089-48). This work was also supported by the French National Agency through the Recherche Hospital-Universitaire-Cardiac & Skeletal Muscle Alteration in Relation to Metabolic Diseases and Ageing: Role of Adipose Tissue (RHU-CARMMA) Grant ANR-15-RHUS-0003. Dr Canoui-Poitrine has epidemiologic expertise and participated on a scientific committee for an observational study in Parkinson's disease, and received honoraria from ABBVIE, France. Dr. Moulin has participated in investigator clinical trials for Sanofi, Pierre Fabre, and Merck Sharp & Dohme; has served on the advisory board of Sanofi; has spoken at symposia for Sanofi, Merck Sharp & Dohme, and Novo Nordisk; and has participated in academic congresses for Janssen, Boehringer, Amgen, and AstraZeneca. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Drs. Ernande and Audureau contributed equally to this work. Drs. Marwick and Derumeaux contributed equally to this work and are joint senior authors. Maurizio Galderisi, MD, served as Guest Editor for this paper.

Listen to this manuscript's audio summary by JACC Editor-in-Chief Dr. Valentin Fuster.